Informations générales (source: ClinicalTrials.gov)
Assessment of the Knowledge and Needs of Patients With AMD Before a Therapeutic Patient Education Program is Put in Place (DEMELE)
Interventional
N/A
University Hospital, Limoges (Voir sur ClinicalTrials)
mars 2019
janvier 2021
29 juin 2024
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision
you need for "straight-ahead" activities such as reading, sewing, and driving. AMD
affects the macula, the part of the eye that allows you to see fine detail
The purpose of the study is to describe in patients with AMD and depending on the nature
of their pathology (neovascular or atrophic):
(i) knowledge about their pathology (risk factors, symptoms, treatments, self-monitoring
tool), (ii) their needs and (iii) impact on their daily lives
This study is to make an inventory of the knowledge of patients with AMD about their
disease and risk factors using a questionnaire (Appendix 1) and to identify their needs,
the impact of the disease on their daily lives during individual interviews by raising
the recurrent data and confronting them during the focus group. The information gathered
will enable the construction of a therapeutic education program for better patient care
and to strengthen the patient's capacities so that he becomes an actor in his change
throughout his care project.
This a 3 steps study:
1. 200 patients will be enrolled and answer a questionnaire on knowledge of the disease
2. Two groups of 20 patients will be selected to participate to a semi-structured
individual interviews
3. Two focus groups of 10 patients will be organized to assess needs, expectations,
satisfactions or to better understand opinions, motivations or behaviors.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Service d'Ophtalmologie - 87042 - Limoges - France | Catherine DE SOUSA, Nurse | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patient with AMD (neovascular and atrophic) whatever the stage of the disease
- Patient over 50
- Patient affiliated to a social security scheme
- Written informed consent of the patient
- Patient with AMD (neovascular and atrophic) whatever the stage of the disease
- Patient over 50
- Patient affiliated to a social security scheme
- Written informed consent of the patient
- Patient unable to understand the information, fill out the questionnaires
- Patient with diabetic retinopathy